comparemela.com
Home
Live Updates
Algernon Pharmaceuticals Announces Grant of U.S. Patent for Repirinast in NAFLD and NASH : comparemela.com
Algernon Pharmaceuticals Announces Grant of U.S. Patent for Repirinast in NAFLD and NASH
VANCOUVER, British Columbia, Sept. 06, 2023 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (the “Company” or “Algernon”) (CSE: AGN) (FRANKFUR...
Related Keywords
Japan
,
Canada
,
United States
,
China
,
United Kingdom
,
Vancouver
,
British Columbia
,
British
,
Canadian
,
Christopherj Moreau
,
,
Mitsubishi
,
Algernon Pharmaceuticals
,
Canadian Securities Exchange
,
Trademark Office
,
Algernon Pharmaceuticals Inc
,
Neither The Canadian Securities Exchange
,
Company Or Algernon
,
United States Patent
,
Treating Non Alcoholic Steatohepatitis
,
Mitsubishi Tanabe Pharma
,
Zhejiang Ausun Pharmaceutical
,
Algernon Neuroscience
,
Market Regulator
,
comparemela.com © 2020. All Rights Reserved.